Ahmedabad based Intas Pharmaceutical Ltd has entered into a marketing tie-up with California based Insightra Medical Inc to market medical devices in India and Nepal.
“A separate subsidiary called Intas Medi Device was floated in April this year, and we will source and market devices used in cardiovascular therapies like coronary stents and gynaecological surgeries etc,” informed Jayesh Shah, chief financial officer of Intas Pharma. Shah said that it is still premature to talk amount annual volume of medical devices that it would source, but added that the medical devices market is a fast growing one. He also added that the company has invested close to $1-2 million to forge the partnership.
Insightra Medical Inc is a major surgical device manufacturer in the US. It focuses on medical devices for general surgery, uro-gynaecology, cardiology, cardiac surgery and therapeutic colonoscopic surgery. Besides the US, Insightra has presence in Europe and Asia and through sales and marketing offices acorss Europe and South Africa, it currently sells its products across 50 markets.
Intas, on the other hand, has its presence in Latin America and CIS nations, apart from the European and African markets. “This is an important strategy for Intas. It allows us to approach our customers with a broader offering of products covering a wider spectrum of treatment options. The lines between pharmaceutical therapies and medical device therapies are starting to overlap. Having access to both technologies will be important for our future growth,” said Nimish Chudgar , managing director, Intas.
Thanks to the tie-up, now Intas will have direct access to a range of IAB catheters, stents and other cardiovascular products.
It will also have access to new hernia products for both ventral and inguinal hernia, which is a major multimillion dollar market world over. And in the pipeline will be a range of new duel drug eluting stents, which is a growing market in India.
Intas has registered a net sales of Rs 1500 crore in 2009-10.
